amgen glp-1 drug Amgen's AMG-133 shows potential in competing with GLP-1RA obesity therapies What to know about MariTide,

Regulatory approvals for obesity-specific indications and the shifting perception of obesity as a chronic medical condition rather than a lifestyle issue are further improving market momentum

SURPASS-1 shows that tirzepatide alone, at all doses, was superior to placebo and revealed a dose-dependent reduction of HbA1c by up to 2.07% (p 10% weight loss can be disease modifying and may even lead to disease remission [38]

Aon said the GLP-1 users experienced a 44% reduction in hospitalizations caused by cardiovascular events such as strokes and heart attacks, as well as lower claims for pneumonia, inflammatory bowel disease, osteoporosis, and alcohol and substance use

Dont worry

The hyperactive hypothalamicpituitarygonadal axis in PCOS patients results in excessive ovarian androgen production in theca cells via upregulation of CYP17A1 enzyme activity ( de novo lipid synthesis, leading to excess lipid accumulation and lipotoxicity (34, 35)

Mental stress impacts the nervous system and elevates cortisol levels which promotes energy storage and invites food cravings for ultra-processed comfort foods